Q3 FY26 Results: 9M Revenue Down 8.5% YoY, PAT Falls to Rs 19.94 Cr

Revenue declinedEBITDA margin compressionResults View source PDF Explain this filing

ALBERTDAVD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.2%Reaction day

₹712.00

prior close

₹765.05

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%+4.7% vs market

Pharmaceuticals peers, median of 157sector-0.7%+4.9% vs sector

On the reaction day the stock moved 4.7 pts more than Nifty Microcap 250 and 4.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.6

10m

-0.3

15m

-0.4

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.2-0.5+4.7-0.7+4.9

Next day

+5.8-2.0+7.7-1.4+7.2

+3.2-2.7+5.9-2.1+5.4

+2.9-1.7+4.7-1.6+4.6

+2.9-1.4+4.3-1.6+4.5

+0.3-2.8+3.1-2.5+2.8

+1.0-2.8+3.8-2.9+3.9

15d

-4.8-8.4+3.6-6.5+1.7

-4.4-9.1+4.7-6.6+2.3

+0.6-4.0+4.7-3.5+4.1

+11.0+2.6+8.3+0.7+10.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Albert David posted Q3 FY26 revenue of Rs 89.93 cr (up 8.2% YoY) and PAT of Rs 15.30 cr versus a loss of Rs 9.39 cr in Q3 FY25. For nine months, revenue declined 8.5% YoY to Rs 247.73 cr from Rs 270.87 cr, and PAT fell about 27.6% to Rs 19.94 cr from Rs 27.53 cr. Total income for 9M stood at Rs 280.03 cr versus Rs 305.57 cr. EPS for 9M was Rs 34.94 versus Rs 48.24. Statutory auditor L.B. Jha & Co. LLP issued an unmodified limited review report.

Likely market impact

Mixed picture: quarterly recovery offset by weaker 9M performance with revenue and profit declines, suggesting margin pressure for shareholders.